Clinical Trial Update: Machine Learning for Predicting and Managing Quality of Life in Lung Cancer Immunotherapy Patients [NA]

View source ↗

Summary

This clinical trial uses machine learning to predict and manage quality of life in lung cancer patients undergoing immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Second Affiliated Hospital of Zunyi Medical University | Conditions: Lung Cancer Patients | NA | Status: NOT_YET_RECRUITING